Thermo Fisher Scientific | TMO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.6B 330M 2026-06
Agilent USD 465M 11M 2026-03
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 212M 400K 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Bruker USD 238.9M 3.2M 2026-06
Charles River Laboratories USD 228.9M 69.47M 2026-06
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 364M 13M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
General Electric Aerospace USD 1.13B 47M 2026-06
Henry Schein USD 831M 22M 2026-06
Illumina USD 273M 1000K 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Medtronic 2.96B 9M 2025-12
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Olympus JPY 125.03B 14.31B 2026-06
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 529M 25M 2026-06
Repligen USD 76.62M 82K 2026-06
Revvity USD 278.58M 24.69M 2026-06
Stryker USD 2.12B 32M 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Veracyte USD 55.71M 4.87M 2026-06
Waters USD 405M 11M 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06